Clinical Trial Update: Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial [Phase 4]

View source ↗

Summary

Phase 4 open-label trial assessing Sofosbuvir/Ledipasvir for Hepatitis C in patients with transfusion-dependent thalassemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Thalassemia

Drugs mentioned

• Sofosbuvir/Ledipasvir (sofosbuvir/ledipasvir)

Snippet

Sponsor: Ala'a Sharara | Conditions: Thalassemia, Hepatitis C | Phase 4 | Status: COMPLETED